Utpal Koppikar

Insider Reports History

Entity
Individual
Location
C/O Atara Biotherapeutics, Inc., 611 Gateway Blvd, Suite 900, South San Francisco, California
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Utpal Koppikar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. Chief Financial Officer Common Stock 182K $70.8K $0.39 Mar 2, 2023 Direct
C4 Therapeutics, Inc. Director Stock Option (Right to Buy) 32.5K Jun 20, 2024 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 Nov 19, 2021 Direct

Insider Reports Filed by Utpal Koppikar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
CCCC C4 Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
ATRA Atara Biotherapeutics, Inc. Mar 2, 2023 1 -$24.9K 4 Mar 6, 2023 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Feb 8, 2023 1 $31.7K 4 Feb 10, 2023 Director
ATRA Atara Biotherapeutics, Inc. Feb 7, 2023 1 -$13.6K 4 Feb 9, 2023 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. Nov 16, 2022 2 -$28.1K 4 Nov 18, 2022 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. Aug 16, 2022 1 -$29.9K 4 Aug 18, 2022 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. Jun 8, 2022 1 -$33K 4 Jun 10, 2022 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. May 17, 2022 2 -$29.7K 4 May 19, 2022 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Mar 16, 2022 1 $0 4 Mar 17, 2022 Director
CCCC C4 Therapeutics, Inc. Mar 16, 2022 0 $0 3 Mar 17, 2022 Director
ATRA Atara Biotherapeutics, Inc. Mar 1, 2022 4 -$37.1K 4 Mar 3, 2022 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. Feb 7, 2022 1 -$36.1K 4 Feb 9, 2022 Chief Financial Officer
FLXN Flexion Therapeutics Inc Nov 19, 2021 1 $0 4 Nov 19, 2021 Director
ATRA Atara Biotherapeutics, Inc. Nov 16, 2021 1 -$62.6K 4 Nov 18, 2021 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. Aug 17, 2021 1 -$44.9K 4 Aug 19, 2021 Chief Financial Officer
FLXN Flexion Therapeutics Inc Jul 9, 2021 1 $0 4 Jul 12, 2021 Director
FLXN Flexion Therapeutics Inc Jul 9, 2021 0 $0 3 Jul 12, 2021 Director
ATRA Atara Biotherapeutics, Inc. Jun 8, 2021 1 -$81.8K 4 Jun 9, 2021 Chief Financial Officer
ATRA Atara Biotherapeutics, Inc. May 18, 2021 1 -$52.6K 4 May 20, 2021 Chief Financial Officer